GFR in a 30-Year-Old Patient
A GFR of approximately 100-107 mL/min/1.73 m² is normal for a healthy 30-year-old adult, and any value below 60 mL/min/1.73 m² warrants evaluation for chronic kidney disease (CKD). 1, 2
Normal GFR Values at Age 30
- The mean GFR in healthy young adults is approximately 107 mL/min/1.73 m² and remains stable until age 40, after which physiological decline begins 1
- Normal GFR values are largely over 60 mL/min/1.73 m² in healthy subjects before age 70 2
- There is no significant difference in GFR between men and women in this age group when properly indexed to body surface area 1
Defining Abnormal GFR and CKD
CKD is defined as abnormalities of kidney structure or function present for >3 months with health implications 3, 4:
- GFR <60 mL/min/1.73 m² defines decreased kidney function and meets criteria for CKD (Stage 3 or higher) 5
- Alternatively, GFR ≥60 mL/min/1.73 m² with albuminuria (ACR ≥3 mg/mmol or ≥30 mg/g) for ≥3 months also defines CKD 5, 3
- A single abnormal measurement is insufficient—abnormalities must persist for at least 3 months 3, 4
Risk Stratification by GFR and Albuminuria
Use the KDIGO CGA classification system (Cause, GFR category, Albuminuria category) to stratify risk 5:
GFR Categories:
- G1: ≥90 mL/min/1.73 m² (normal/high)
- G2: 60-89 mL/min/1.73 m² (mildly decreased)
- G3a: 45-59 mL/min/1.73 m² (mild-moderate decrease)
- G3b: 30-44 mL/min/1.73 m² (moderate-severe decrease)
- G4: 15-29 mL/min/1.73 m² (severe decrease)
- G5: <15 mL/min/1.73 m² (kidney failure) 6
Risk Strata:
- Low risk: GFR ≥60 with albuminuria <3 mg/mmol 5
- Moderate risk: GFR ≥60 with albuminuria 3-30 mg/mmol OR GFR 45-59 with albuminuria <3 mg/mmol 5
- High risk: GFR ≥60 with albuminuria >30 mg/mmol OR GFR 45-59 with albuminuria 3-30 mg/mmol OR GFR 30-44 with albuminuria <3 mg/mmol 5
- Very high risk: GFR <30 with any albuminuria OR GFR 30-59 with albuminuria >30 mg/mmol 5
Evaluation Approach
Initial Assessment:
- Use serum creatinine with eGFRcr (CKD-EPI equation) as the initial test 4, 7
- Measure albuminuria using albumin-to-creatinine ratio (ACR) in a spot urine sample 8, 6
- Repeat testing after 3 months to confirm chronicity before diagnosing CKD 3, 4
When Greater Accuracy is Needed:
- Measure cystatin C and calculate eGFRcr-cys when eGFRcr may be inaccurate (extremes of muscle mass, recent changes in muscle mass, certain medications) 4, 9
- eGFRcr-cys is more accurate than eGFRcr alone, particularly in older adults, but this principle applies across age groups 4, 9
- Consider measured GFR (mGFR) using exogenous filtration markers (iohexol, iothalamate, ⁵¹Cr-EDTA, ⁹⁹ᵐTc-DTPA) when treatment decisions require the highest accuracy 4, 7, 10
Common Pitfalls:
- Small fluctuations in GFR are common and not necessarily indicative of progression—look for sustained changes 11
- A single eGFR measurement has significant biological and measurement variability; changes >20% are needed to indicate true progression 10
- eGFRcr may be inaccurate in patients with very low or very high muscle mass, requiring cystatin C-based estimation 4, 12
Management Based on GFR
For GFR 30-44 mL/min/1.73 m² (Stage G3b):
- Assess for reversible causes of kidney dysfunction 11
- Consider nephrology referral for specialist evaluation 11
- Initiate renoprotective therapy based on albuminuria status and comorbidities 8
For GFR <30 mL/min/1.73 m² (Stage G4-G5):
- Renal replacement therapy should be considered when eGFR <30 mL/min/1.73 m² 6
- This represents very high risk for progression to kidney failure, cardiovascular events, and mortality 5
- Nephrology referral is essential at this stage 11
Therapeutic Interventions:
- Start RAS inhibitors (ACEi or ARB) for patients with albuminuria (A2 or A3 categories) 8
- SGLT-2 inhibitors are recommended for patients with eGFR ≥20 mL/min/1.73 m² and albuminuria ≥200 mg/g, or with heart failure 8
- Blood pressure target <120/80 mmHg (or as tolerated without hypotension symptoms) 8
- Protein intake approximately 0.8 g/kg/day for patients with established CKD 6